 DIAPRESAN D
|
Montpellier
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.rec.x30 | $32.628,45 | (17/07/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $14.895,33 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $13.228,51 |
|
|
|
|
| 160/25 mg comp.rec.x30 | $39.348,42 | (24/10/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $17.260,25 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $15.093,10 |
|
|
|
|
| 320/12.5 mg comp.rec.x30 | $41.346,51 | (24/10/25) |
| PAMI |
|
| AF $16.308,72 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $25.063,23 AF $16.283,28 |
|
|
|
|
| 320/25 mg comp.rec.x30 | $41.598,98 | (24/10/25) |
|
|
|
| 80/12.5 mg comp.rec.x 30 | $27.269,90 | (24/10/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $11.572,84 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $9.510,90 |
|
|
|
|
| |
